Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative

Details for Australian Patent Application No. 2009201233 (hide)

Owner Santen Pharmaceutical Co., Ltd.

Inventors Tokai, Maki; Honda, Takahiro; Niwa, Masashi; Osumi, Yaeko; Fujimura, Kenichi; Kohno, Shin-ichi

Agent Griffith Hack

Pub. Number AU-B-2009201233

Parent 2003220894

Filing date 30 March 2009

Wipo publication date 23 April 2009

Acceptance publication date 5 July 2012

International Classifications

C07D 277/66 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/428 - condensed with carbocyclic rings

A61P 19/02 Drugs for skeletal disorders

A61P 19/06 Drugs for skeletal disorders

A61P 25/04 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 Drugs for specific purposes, not provided for in groups

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 April 2009 Application Open to Public Inspection

  Published as AU-B-2009201233

23 April 2009 Complete Application Filed

5 July 2012 Application Accepted

  Published as AU-B-2009201233

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201234-A gaming system and method of gaming

2009201232-Managing media files from multiple sources